ENMD
Navigation Links
ENMD in Medical News
EntreMed Reports Second Quarter 2009 Financial Results
... ROCKVILLE, Md., Aug. 6 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported financial results for the three and six...EntreMed Reports First Quarter 2009 Financial Results
... ROCKVILLE, Md., May 6 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today reported financial res...EntreMed Reports Fourth Quarter and Year-End 2008 Financial Results
... ROCKVILLE, Md., March 12 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today reported results for t...EntreMed Focuses on Development of ENMD-2076
...agement Realigned to Provide Full Support for Clinical Activities ROCKVILLE, Md., Dec. 15 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company announced today plans to focus the Company's resources on its most promising near-term product candidate, E...EntreMed Reports Clinical Program Progress and Company Update
... ROCKVILLE, Md., Nov. 12, /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, reported corporate and clini...EntreMed to Present at the Rodman and Renshaw 10th Annual Healthcare Conference
... ROCKVILLE, Md., Nov. 7 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced today that James S....EntreMed Teams with JSB-Partners to Expedite Partnering of its Aurora Kinase Program
... Additional Resources to Accelerate ENMD-2076 Partnering Efforts ROCKVILLE, Md., Aug. 12 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that it has ...EntreMed to Present at the BIO 2008 Annual International Convention
... ROCKVILLE, Md., June 13 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced today that James S....EntreMed to Present at The Rodman and Renshaw 5th Annual Global Healthcare Conference
... ROCKVILLE, Md., May 13 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced today that James S....Dr. Ronald E. Cape to Retire from EntreMed Board of Directors
... ROCKVILLE, Md., April 7, 2008 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the retireme...ENMD in Medical Technology
Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients
...ded Clinical Program Now Includes Solid and Hematological Malignancies ROCKVILLE, Md., June 1 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer today announced the presentation of clinical data for i...EntreMed Presents Initial Clinical Results for ENMD-2076
...ug Designation and Canadian CTA Accelerate ENMD-2076 Program Momentum ROCKVILLE, Md., Feb. 9 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced recent devel...EntreMed Receives New Patent for 2-Methoxyestradiol Analogs
... Patent Covers Compositions and Methods ROCKVILLE, Md., June 11 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the issuance...EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting
... Antitumor Activity Demonstrated in Metastatic Breast Cancer Patients ROCKVILLE, Md., June 3 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the presenta...EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
...pounds Demonstrate Potent Antitumor Activity in a Variety of Tumor Types ROCKVILLE, Md., April 16 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the presenta...EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting
...ral Presentation During the "New Drugs on the Horizon 2" Special Session ROCKVILLE, Md., April 11 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced it will pres...EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
...elective Kinase Inhibitor Phase 1 Trial in Advanced Cancer Patients ROCKVILLE, Md., April 9, 2008 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that it has ...EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
... Phase 1 Study to be Conducted in Advanced Cancer Patients ROCKVILLE, Md., April 2, 2008 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that it has ...EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
... Multi-Center Clinical Trial to be Conducted in Canada ROCKVILLE, Md., Jan. 23 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the commence...EntreMed to Present at The New York Society of Security Analysts Industry Conference
... ROCKVILLE, Md., Dec. 5 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced today that James S....ENMD in Biological Technology
EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting
...nical Program Adds Leukemia Clinical Study and Orphan Drug Designation ROCKVILLE, Md., May 15 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer today announced presentations for three of its clinical...EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma
... ROCKVILLE, Md., Dec. 9 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that it has ...EntreMed to Present at the New York Society of Security Analysts Industry Conference
... ROCKVILLE, Md., Nov. 25 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced today that a Compa...EntreMed's MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial
... Phase 2 Randomized Study Under Consideration ROCKVILLE, Md., Nov. 10 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that it has ...EntreMed Reports Third Quarter 2008 Financial Results
... ROCKVILLE, Md., Nov. 6 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today reported results for t...Antiangiogenic Role of 2ME2 Demonstrated in Rheumatoid Arthritis Models
... ROCKVILLE, Md., Nov. 3 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the publicat...EntreMed's ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
... ROCKVILLE, Md., Oct. 23 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the presenta...EntreMed to Present at BioPartnering Europe Conference
... ROCKVILLE, Md., Oct. 10 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced today that Thomas H...EntreMed Announces Stock Listing Transfer to Nasdaq Capital Market
... ROCKVILLE, Md., Oct. 2 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that it has ...EntreMed Reports Second Quarter 2008 Financial Results
... EntreMed to Conduct Update Call on Tuesday, August 12, 2008 ROCKVILLE, Md., Aug. 6 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: enmd ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today reported financial res...Other TagsTartTartTartTartTarttroutsensationmonitorsOther Contentsmismatchmismatchmismatchmismatchmismatchmitochondriamitochondriamitochondriamitochondriamitochondriamitochondrialmitochondrialmitochondrialmitochondrialmitochondrialmitochondrialmitochondrialmitochondrialmodificationmodificationmodificationmodificationmodificationmodificationmodificationteethteethteethteethteethteethteethmolarmolarmolarmolarmolar
unprovenGambiaopposesretreatingcherriesTartPeninsulaIberiantroutownershipsensationmonitorsdormantInsulator
(Date:11/27/2009)...e/ - Uploadable USB pedometers may be new, but the...ination of advanced accelerometer functionality an...ncern over the accuracy of self-reported data. It,...oved participation in a fitness program. ,, Cor...suppliers to integrate this technology. "Our healt...
(Date:11/27/2009)...ov. 27 Team Garmin-Slipstream, the...d to ethical sporting and developing the next gene...it will become Team Garmin-Transitions with the ad...the team. Transitions Optical is the world,s leadi...most advanced photochromic technology in the wides...
(Date:11/27/2009)...27 Allrecipes.com , the world,s...raffic numbers, with more than 2.8 million visitor...icture of what was served on the biggest food holi...2009 weighed in at 2,225 calories per serving, a 5...g to the Allrecipes site, Sweet Potato Pie I sto...
(Date:11/26/2009)... -- With cold and flu season upon us, it,s more im...rol the spread of infections and avoid illness. ,...elves healthy, but to avoid transmitting illness i...ertified in infection-control), nursing director f...spital for Special Surgery (HSS) in Manhattan. ,...
(Date:11/26/2009)...nal rollercoaster, study finds , , THURS...factor meets the jubilant sports fan. , A new s...who root for the winning team -- enjoy the greates...nd victory was in doubt, producing feelings of wor...giving weekend as you,re glued to the TV set, watc...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3[0] New USB technology adds accountability and convenience to wellness programs[0] Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor[0] It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories[1] Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use[0] Watching the Nail-Biting Big Game Hurts So Good
(Date:11/25/2009)...ifornia Institute of Technology (Caltech) have unc...or in the fruit fly, Drosophila melanogaster . ,...ationship between the neurotransmitter dopamine an... are described in the December issue of the journa...ly about 20,000 neurons and has long been consider...
(Date:11/25/2009)... lives. In addition to mammalian immune systems th...led bacteriophages, viruses that kill half the bac...a and another class of microorganisms called archa...as deep-sea volcanic vents) manage just fine, than...e system that helps protect them from many viruses...
(Date:11/25/2009)... Death Research Laboratory in the University of Ha...prestigious Johnson & Johnson Focused Funding gran...ll damage in Parkinson,s disease. The award, which...innovation and excellence in science, was announce...onth at an event at the Hyatt Regency Hotel in New...
Breaking Biology News(10 mins):Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2US Oncology Named to InformationWeek 500 as Top User of Business Technology 57255 1US Oncology Named to InformationWeek 500 as Top User of Business Technology 57255 2US Oncology Named to InformationWeek 500 as Top User of Business Technology 57255 3US Oncology Named to InformationWeek 500 as Top User of Business Technology 57255 4US Oncology Named to InformationWeek 500 as Top User of Business Technology 57255 5US Oncology Named to InformationWeek 500 as Top User of Business Technology 57255 6The Lustgarten Foundation Says Patrick Swayzes Death Highlights the Need for Increased Research into Early Diagnosis and Treatment of Pancreatic Cance 57253 1The Lustgarten Foundation Says Patrick Swayzes Death Highlights the Need for Increased Research into Early Diagnosis and Treatment of Pancreatic Cance 57253 2Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects New Report Says 5006 1Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects New Report Says 5006 2Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects New Report Says 5006 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |